Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pui Yan Ho

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Biomaterials|September 9, 2022
Nanoradiosensitizer with good tissue penetration and enhances oral cancer radiotherapeutic effectDi Jing, Nian Jiang, Fengyi Wang, et al.
Oncotarget|January 11, 2020
Head and neck squamous cancer progression is marked by CLIC4 attenuation in tumor epithelium and reciprocal stromal upregulation of miR-142-3p, a novel post-transcriptional regulator of <i>CLIC4</i>Brandi L Carofino, Kayla M Dinshaw, Pui Yan Ho, et al.
Viruses|February 27, 2026
Antiviral Activity of Remdesivir and Obeldesivir Against SARS-CoV-2 Omicron Subvariants That Were Circulating from September 2023 Through June 2025Lauren Rodriguez, Jiani Li, Dong Han, et al.
Biomaterials|May 5, 2019
Creatine based polymer for codelivery of bioengineered MicroRNA and chemodrugs against breast cancer lung metastasisJieni Xu, Jingjing Sun, Pui Yan Ho, et al.
Cancer Letters|November 4, 2018
Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse modelsMei-Juan Tu, Pui Yan Ho, Qian-Yu Zhang, et al.
Antiviral Research|December 31, 2025
SARS-CoV-2 Resistance Analyses From the Phase 3 OAKTREE Study of Obeldesivir in Low-Risk Nonhospitalized Participants With COVID-19Lauren Rodriguez, Yu Hu, Jiani Li, et al.
Theranostics|March 23, 2021
<i>In vivo</i> fermentation production of humanized noncoding RNAs carrying payload miRNAs for targeted anticancer therapyPeng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, et al.
Nature Microbiology|November 4, 2025
Structural and mechanistic insights into herpesvirus helicase-primase and its therapeutic inhibitorsQing Yao, Alexandre Mercier, Arabinda Nayak, et al.
Stem Cell Research & Therapy|October 30, 2024
Targeted hematopoietic stem cell depletion through SCF-blockadeYan Yi Chan, Pui Yan Ho, Carla Dib, et al.
Antiviral Research|January 21, 2026
SARS-CoV-2 Resistance Analyses From the Phase 3 BIRCH Study of Obeldesivir in High-Risk Nonhospitalized Participants With COVID-19Charlotte Hedskog, Lauren Rodriguez, Yu Hu, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Biomaterials|September 9, 2022
Nanoradiosensitizer with good tissue penetration and enhances oral cancer radiotherapeutic effectDi Jing, Nian Jiang, Fengyi Wang, et al.
Oncotarget|January 11, 2020
Head and neck squamous cancer progression is marked by CLIC4 attenuation in tumor epithelium and reciprocal stromal upregulation of miR-142-3p, a novel post-transcriptional regulator of <i>CLIC4</i>Brandi L Carofino, Kayla M Dinshaw, Pui Yan Ho, et al.
Viruses|February 27, 2026
Antiviral Activity of Remdesivir and Obeldesivir Against SARS-CoV-2 Omicron Subvariants That Were Circulating from September 2023 Through June 2025Lauren Rodriguez, Jiani Li, Dong Han, et al.
Biomaterials|May 5, 2019
Creatine based polymer for codelivery of bioengineered MicroRNA and chemodrugs against breast cancer lung metastasisJieni Xu, Jingjing Sun, Pui Yan Ho, et al.
Cancer Letters|November 4, 2018
Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse modelsMei-Juan Tu, Pui Yan Ho, Qian-Yu Zhang, et al.
Antiviral Research|December 31, 2025
SARS-CoV-2 Resistance Analyses From the Phase 3 OAKTREE Study of Obeldesivir in Low-Risk Nonhospitalized Participants With COVID-19Lauren Rodriguez, Yu Hu, Jiani Li, et al.
Theranostics|March 23, 2021
<i>In vivo</i> fermentation production of humanized noncoding RNAs carrying payload miRNAs for targeted anticancer therapyPeng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, et al.
Nature Microbiology|November 4, 2025
Structural and mechanistic insights into herpesvirus helicase-primase and its therapeutic inhibitorsQing Yao, Alexandre Mercier, Arabinda Nayak, et al.
Stem Cell Research & Therapy|October 30, 2024
Targeted hematopoietic stem cell depletion through SCF-blockadeYan Yi Chan, Pui Yan Ho, Carla Dib, et al.
Antiviral Research|January 21, 2026
SARS-CoV-2 Resistance Analyses From the Phase 3 BIRCH Study of Obeldesivir in High-Risk Nonhospitalized Participants With COVID-19Charlotte Hedskog, Lauren Rodriguez, Yu Hu, et al.
Pageof 3